Does Wegovy Cause Muscle Loss? Side Effects and What You Can Do

Step 1: understanding why weight loss takes muscle with it

When the body runs a consistent calorie deficit (whether driven by appetite suppression, dietary change, or a combination) it draws on both fat and lean tissue for energy. This is well-established physiology, not a flaw specific to Wegovy. The STEP 1 trial, published in the New England Journal of Medicine, showed that participants on 2.4 mg semaglutide lost an average of around 15% of their body weight over 68 weeks. What the headline figure doesn't show is composition: analyses of that weight loss indicate roughly 30–40% of it came from lean mass, including muscle, with the remainder from fat. That ratio is broadly comparable with other forms of significant calorie restriction (it isn't unique to GLP-1 medicines) but the scale of weight loss means the absolute amount of muscle lost can be meaningful.

Wegovy works by mimicking the GLP-1 hormone, reducing appetite and slowing gastric emptying. The NHS's semaglutide information explains the mechanism clearly. Reduced appetite is the intended effect; the challenge is that eating significantly less also means eating less protein, which is the primary nutritional input for maintaining and building muscle.

Step 2: the factors that influence how much muscle you keep

Protein intake is the single most modifiable factor. When overall calorie intake falls, the body's protein requirement doesn't fall at the same rate, if anything, it rises relative to total calories, because muscle tissue needs adequate amino acids to maintain itself under conditions of energy scarcity. Most clinical guidance for people on weight-loss treatment suggests prioritising protein at every meal, aiming for adequate daily intake before filling up on carbohydrate or fat.

Resistance training is the second lever. Strength exercise signals the body to preserve and rebuild muscle tissue even when energy balance is negative. This doesn't require a gym membership or heavy weights, bodyweight work, resistance bands, or any progressive load done consistently produces the adaptive signal. Many people find it easier to keep a short routine when the equipment lives somewhere visible; keeping a resistance band in your gym bag rather than a drawer makes it likelier to be used.

The pace of weight loss matters too. Very rapid loss correlates with a higher proportion of lean tissue shed. The titration schedule for Wegovy (starting low and increasing gradually under prescriber guidance) is partly designed to manage side effects, but the slower trajectory also tends to produce somewhat better lean-mass outcomes than crash approaches. A broader overview of what semaglutide treatment involves is on our Wegovy information page.

Step 3: distinguishing muscle loss from other Wegovy side effects

Fatigue and physical weakness are among the commonly reported experiences during dose increases. The NHS notes that nausea, diarrhoea, constipation, vomiting, and headache are the most frequent side effects, usually most noticeable in the first weeks after a dose step. It's easy to attribute general tiredness to muscle loss when it may be the result of reduced calorie intake, GI disruption, or dehydration from nausea and vomiting. These are different problems with different responses.

Genuine progressive muscle weakness (not just post-illness fatigue) over weeks of stable dosing is worth raising with your prescriber. So is unintentional loss of strength or function that isn't explained by calorie restriction alone. If you're also experiencing significant nausea or poor appetite and haven't been eating much protein, address that first: it's the more likely explanation and the one you can act on directly. Our page on semaglutide side effects covers the broader picture, and the Wegovy side-effects hub groups them by type.

When to get medical help

Some symptoms during Wegovy treatment need prompt attention rather than a wait-and-see approach. Severe, persistent abdominal pain (particularly pain that radiates to the back, with or without vomiting) may indicate acute pancreatitis, which the MHRA highlighted in its January 2026 Drug Safety Update on GLP-1 medicines. Seek urgent medical help for this.

Other symptoms that warrant prompt contact with a clinician include: signs of serious dehydration (dizziness, very dark urine, inability to keep fluids down for more than 24 hours); symptoms of a severe allergic reaction; significant changes in mood, unusual low mood, or any thoughts of self-harm. These aren't expected consequences of treatment and shouldn't be managed alone.

For side effects you believe are related to Wegovy, you can report them directly to the MHRA via the Yellow Card scheme, this is open to patients and carers as well as healthcare professionals. If you've noticed more shedding than usual, our page on Wegovy hair loss covers what the evidence says and what tends to help, and our separate guide to hair loss as a Wegovy side effect is a good starting point if you're still trying to work out whether the two are connected. If you're unsure whether any shedding you've noticed is directly linked to the medication itself, our page looking at whether hair loss is a side effect of Wegovy walks through what the evidence currently shows. And if you'd like to talk through side effects with a clinician before deciding whether treatment is right for you, our free consultation page is where to start.